 |
|
Home | Morgan Stanley (NYSE: MS) Lowers Price Target on Eli Lilly (NYSE: LLY) |
 |
Morgan Stanley (NYSE: MS) Lowers Price Target on Eli Lilly (NYSE: LLY)
|
 |
- September 10, 2010
-
Morgan Stanley (NYSE: MS) analysts lowered its price target on shares of Eli Lilly (NYSE: LLY) to $32.00 saying that the company could face lower product sales, while maintaining an “underweight” rating in a research note to investors on Wednesday. Eli Lilly and Company discovers, develops, manufactures, and sells products in one business segment, pharmaceutical [...]This article (Morgan Stanley (NYSE: MS) Lowers Price Target on Eli Lilly (NYSE: LLY)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://feedproxy.google.com/~r/AmericanBankingNews/~3/Dy0DdeBOtxU/
|
 |
|
 |
|
 |
